Adial Pharmaceuticals Announces 1-For-25 Reverse Stock Split To Regain Compliance With Nasdaq’s Minimum Bid Price Requirement And Reduce The Public Float
Adial Pharmaceuticals, Inc. (NASDAQ:ADIL, ADILW)))) ("Adial" or the "Company"), a clinical-stage biopharmaceutical company focused on developing therapies for the treatment and prevention of